What is Vicapsys Life Sciences Price-to-Operating-Cash-Flow?
As of today (2024-05-17), Vicapsys Life Sciences's share price is $0.444.
Vicapsys Life Sciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.01. Hence, Vicapsys Life Sciences's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Vicapsys Life Sciences's Price-to-Operating-Cash-Flow or its related term are showing as below:
Vicapsys Life Sciences's Cash Flow from Operations per share for the
three
months ended in Sep. 2023 was $-0.00.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.01.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 54.50% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 75.20% per year.
During the past 6 years, Vicapsys Life Sciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 85.30% per year. The lowest was 54.50% per year. And the median was 81.60% per year.
Vicapsys Life Sciences Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Vicapsys Life Sciences's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vicapsys Life Sciences Price-to-Operating-Cash-Flow Chart
|
Vicapsys Life Sciences Annual Data
|
|
Trend |
Dec08 |
Dec09 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
- |
- |
- |
- |
- |
|
Vicapsys Life Sciences Quarterly Data
|
|
Jun10 |
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
- |
- |
- |
- |
Competitive Comparison of Vicapsys Life Sciences's Price-to-Operating-Cash-Flow
For the Biotechnology subindustry, Vicapsys Life Sciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vicapsys Life Sciences's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Vicapsys Life Sciences's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Vicapsys Life Sciences's Price-to-Operating-Cash-Flow falls into.
Vicapsys Life Sciences Price-to-Operating-Cash-Flow Calculation
Vicapsys Life Sciences's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 0.444 | / | -0.009 |
| = | |
Vicapsys Life Sciences's Share Price of today is $0.444.
Vicapsys Life Sciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Vicapsys Life Sciences (Vicapsys Life Sciences) Business Description
Traded in Other Exchanges
N/A
Address
7778 Mcginnis Ferry Road, Suite 270, Suwanee, GA, USA, 30024
Vicapsys Life Sciences Inc is a biotech company that is engaged in commercializing implantable medical products that incorporate VICAPSYN, inducing a zone of immuno-protection around devices and cells implanted in the human body. The product name VICAPSYN is the company's line of proprietary product candidates that is applied to transplantation therapies and related stem-cell applications in the transplantation field.
Executives
| Moore Bobby M Jr |
10 percent owner |
4125 S.B. MERRION ROAD, LAKELAND FL 33810 |
| Robert Grammen |
10 percent owner |
9180 GALLENA COURT, NAPLES FL 34109 |
| Michael Yurkowski |
director |
1505 ELM STREET, #1504, DALLAS TX 75201 |
| William P. Esping |
10 percent owner |
2828 ROUTH STREET, SUITE 500, DALLAS TX 75201 |
| Rodger Rees |
director |
C/O BONDS.COM GROUP, INC., 1515 SOUTH FEDERAL HIGHWAY, SUITE 212, BOCA RATON FL 33432 |
| Mark Feldmesser |
director |
641 UNIVERSITY BLVE, JUPITER FL 33458 |
| Federico Pier |
director |
1004 PLUM DRIVE, IRVING TX 75063 |
| Ryan Seddon |
director, 10 percent owner |
8120 BELVEDERE ROAD, SUITE 4, WEST PALM BEACH FL 33411 |
Vicapsys Life Sciences (Vicapsys Life Sciences) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VICP has been successfully added to your